Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Boehringer Ingelheim Venture Fund

Status
ACTIVE
Global HQ
United States
Countries of investment
  • Germany
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Health Tech
  • Biotechnology
  • AI
  • Data Science
About
Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.
Min check size
$100K
Max check size
$38.9M
Fund size
NPS

Investment Thesis

The Boehringer Ingelheim Venture Fund invests in pioneering science that offers the potential to provide significant benefits for patients, with investments spanning across various geographies.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Backed by extensive experience in venture capital, the fund manager has successfully executed over 50 investments across various sectors, including healthcare, technology, and life sciences. Active primarily in North America and Europe, the investment strategy emphasizes an operator-first approach, allowing for deep engagement with portfolio companies. Notable exits highlight a strong track record of value creation, particularly in early to growth-stage investments. The manager’s thematic focus on innovation and sustainability positions the fund strategically for future opportunities.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp